SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-030241
Filing Date
2023-11-03
Accepted
2023-11-03 17:24:23
Documents
17
Period of Report
2023-11-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20231103_8k.htm   iXBRL 8-K 50166
2 EXHIBIT 4.1 ex_591031.htm EX-4.1 129720
3 EXHIBIT 10.1 ex_591032.htm EX-10.1 55122
4 EXHIBIT 99.1 ex_591052.htm EX-99.1 19768
9 ex_591052img001.jpg GRAPHIC 5243
  Complete submission text file 0001437749-23-030241.txt   455359

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pbla-20231102.xsd EX-101.SCH 3409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20231102_def.xml EX-101.DEF 11424
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20231102_lab.xml EX-101.LAB 15310
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20231102_pre.xml EX-101.PRE 11584
11 EXTRACTED XBRL INSTANCE DOCUMENT pbla20231103_8k_htm.xml XML 2551
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 231377423
SIC: 2834 Pharmaceutical Preparations